Error detection thresholds for routine real time in vivo dosimetry in HDR prostate brachytherapy

被引:10
|
作者
Mason, Josh [1 ,2 ]
Henry, Ann [1 ,3 ]
Bownes, Peter [1 ]
机构
[1] Leeds Canc Ctr, Leeds, W Yorkshire, England
[2] Imperial Coll Healthcare NHS Trust, London, England
[3] Univ Leeds, Leeds, W Yorkshire, England
关键词
In vivo dosimetry; Prostate brachytherapy; DOSE-RATE BRACHYTHERAPY; VERIFICATION; CANCER;
D O I
10.1016/j.radonc.2020.04.058
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Routine real time in vivo dosimetry (IVD) is performed in HDR prostate brachytherapy to independently verify dose delivery. This study investigates impact of position uncertainty on error detection thresholds for IVD. Methods: IVD is implemented using a microMOSFET placed centrally in the prostate using an additional needle. 144 IVD measurements were made for 15 Gy or 19 Gy single fraction treatments. Needle insertion and treatment planning used real-time trans-rectal ultrasound. Source-MOSFET position thresholds of +/- 1, +/- 2 and +/- 3 mm were used to calculate per-needle and total plan error detection thresholds for the measured dose using an uncertainty analysis based on the treatment plan data. Results: The median dose difference from 144 total plan measurements was -5.2% (range +7.4% to - 17.3%). 3 plans measured outside the total plan error detection threshold for position threshold +/- 1 mm, no plans measured outside the total plan error detection threshold for larger position thresholds. For 2233 individual needle measurements, for position thresholds of +/- 1 mm, +/- 2mm and +/- 3 mm the number of needles outside the per-needle error detection threshold was 103, 25 and 10 respectively and the number of treatments that would have required interruption based on these thresholds for real-time IVD was 66, 16 and 8 respectively. Conclusion: IVD in HDR prostate brachytherapy using a microMOSFET provides a high level of confidence that we are correctly delivering the planned dose to our patients. A +/- 2-3 mm position threshold gives an appropriate balance between error detection and avoiding unnecessary treatment interruptions. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 50 条
  • [41] Real-time optimized intraoperative dosimetry for prostate brachytherapy: A pilot study
    Beyer, DC
    Shapiro, RH
    Puente, F
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (05): : 1583 - 1589
  • [42] Implementation of a real-time, ultrasound-guided prostate HDR brachytherapy program
    Smith, Blake R.
    Strand, Sarah A.
    Dunkerley, David
    Flynn, Ryan T.
    Besemer, Abigail E.
    Kos, Jennifer D.
    Caster, Joseph M.
    Wagner, Bonnie S.
    Kim, Yusung
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2021, 22 (09): : 189 - 214
  • [43] Routine clinical treatment verification in HDR prostate brachytherapy with source tracking
    Hanlon, M. D.
    Smith, R. L.
    Panettieri, V.
    Millar, J. L.
    Matheson, B.
    Haworth, A.
    Franich, R. D.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S88 - S88
  • [44] Time-resolved analysis of clinical dose metrics for HDR brachytherapy error detection
    van Wagenberg, Teun
    Fonseca, Gabriel P.
    Voncken, Robert
    Berbee, Maaike
    van Limbergen, Evert
    Verhaegen, Frank
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S361 - S363
  • [45] Uncertanity of Real Time in Vivo Dosimetry with MOSFET Linear Array in I-125 Prostate Permanent Implant Brachytherapy
    Takahashi, Y.
    Tachibana, H.
    Sumida, I.
    Kozuka, T.
    Ito, A.
    Ogata, T.
    Yoshioka, Y.
    Koizumi, M.
    Yamashita, T.
    Inoue, T.
    MEDICAL PHYSICS, 2008, 35 (06)
  • [46] Separation and rectal dosimetry with a hydrogel spacer inserted during prostate HDR brachytherapy
    Davda, R.
    Pendse, D.
    Mitra, A.
    Prentice, M.
    Melcher, L.
    Rosenfelder, N.
    Singhera, M.
    Patel, R.
    Boutros, M.
    Allen, C.
    Payne, H.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S589 - S590
  • [47] A phantom study of an in vivo dosimetry system using plastic scintillation detectors for real-time verification of 192Ir HDR brachytherapy
    Therriault-Proulx, Francois
    Briere, Tina M.
    Mourtada, Firas
    Aubin, Sylviane
    Beddar, Sam
    Beaulieu, Luc
    MEDICAL PHYSICS, 2011, 38 (05) : 2542 - 2551
  • [48] In vivo dosimetry: Optical fibre characterisation for use in adaptive HDR pelvic brachytherapy
    Houlihan, O.
    Marlow, E.
    Esteve, S.
    Workman, G.
    Byrne, M.
    McGarry, C.
    Grattan, M.
    O'Keeffe, S.
    Prise, K.
    Hounsell, A.
    Jain, S.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S732 - S733
  • [49] A Necessary and Efficient Cerenkov Subtraction Technique for in Vivo Scintillation Dosimetry for HDR Brachytherapy
    Therriault-Proulx, F.
    Beddar, S.
    Briere, T. M.
    Beaulieu, L.
    MEDICAL PHYSICS, 2010, 37 (06) : 3346 - +
  • [50] Establishing a fingerprinting method for fast catheter identification in HDR brachytherapy in vivo dosimetry
    Tho, Daline
    Belanger, Cedric
    Jorgensen, Erik B.
    Tanguay, Jeremie
    Rosales, Haydee M. L.
    Beddar, Sam
    Johansen, Jacob G.
    Kertzscher, Gustavo
    Lavallee, Marie -Claude
    Beaulieu, Luc
    BRACHYTHERAPY, 2024, 23 (02) : 165 - 172